Used as an intermediate in the synthesis of pharmaceuticals, particularly in the production of chiral compounds for active pharmaceutical ingredients (APIs). Its structure, featuring a chiral pyrrolidine ring with cyano and chloroacetyl groups, supports the development of enantiomerically pure drugs, which are critical in treatments where stereochemistry affects biological activity. Commonly employed in the preparation of nootropic agents and cognitive enhancers due to its role in constructing pyrrolidine-based nervous system modulators. Also utilized in research settings for developing novel neuroprotective and anticonvulsant molecules.